AMY HICKS: Open Payments
NPI 1023350618 · MACON, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$300 in 15 payments from 9 companies in 2025. Trend: 2023 $1,037 · 2024 $810 · 2025 $300
Food & beverage: $300
| Company | Payments | Amount |
|---|---|---|
| REVANCE THERAPEUTICS, INC. | 3 | $97 |
| Novo Nordisk Inc | 3 | $57 |
| AstraZeneca Pharmaceuticals LP | 2 | $29 |
| ABBVIE INC. | 2 | $29 |
| PFIZER INC. | 1 | $24 |
| Neurocrine BioSciences, Inc. | 1 | $19 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $16 |
| Amgen Inc. | 1 | $14 |
| GlaxoSmithKline, LLC. | 1 | $14 |
Products named: DAXXIFY, NURTEC ODT, Ozempic, INGREZZA, Wegovy, JARDIANCE, BREZTRI, VRAYLAR.
Industry payments across GA — which companies pay providers there.
